Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
about
Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathwayTranslational research involving oxidative stress and diseases of aging.Melatonin, an inhibitory agent in breast cancer.Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathwayThe efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.What is known about melatonin, chemotherapy and altered gene expression in breast cancerMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Melatonin for the prevention and treatment of cancerStress signaling and the shaping of the mammary tissue in development and cancer.Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring RatsMelatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901.Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.Melatonin: an inhibitor of breast cancer.Melatonin membrane receptors in peripheral tissues: distribution and functionsEffect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell LinesEffects of combination of melatonin and laser irradiation on ovarian cancer cells and endothelial lineage viability.Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells.Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.Therapeutic applications of melatonin.Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach.IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways.Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis.The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α.Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway.Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness.Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.
P2860
Q28386841-3A8E7594-31D2-4447-9A63-8B94E2CE8669Q30464085-9E2AF1D1-7783-441F-A2FA-241507F8A906Q30489143-5064DDF0-3AA1-44A8-A609-A915B0A8CDBFQ31172625-2CCE6801-FA51-47B4-BD1C-DB3B5805C842Q33399301-90F9DD68-273F-4334-A891-69F09591E5CCQ33597963-56E3E6B0-DC08-4179-BD64-325694827AE3Q33624824-8D6132A2-BA10-4BAA-9B31-D303E0748398Q33889427-1E50CF91-3B93-4CDA-882E-B2EA9808D256Q33896062-8057D664-27F7-4650-84C4-DEF55FB1D43FQ34438693-2A58E274-A055-4779-9AD5-F7424AD908D5Q34616091-91E4359D-DD3B-4340-9A34-0E9921EB69B4Q35181910-13AA954F-2052-454F-988D-DF5E397DE682Q35689110-6A78A384-A1ED-4BE1-AC9C-F7614061038DQ35784330-6D46E7F9-38EE-4ED7-8D14-161C444B310FQ35943145-B7F80786-C5E2-4B35-93F2-AB8118B2143AQ36065479-DEA71CC2-9D4F-405E-B1F5-6EEA1EF3B5CFQ36265801-CC1260B4-BF39-4BE4-B75B-A50E0E8AF691Q36367178-614DCB74-2741-4A0B-9403-80AA14C71891Q36671329-B4DFF058-9113-4499-A1A5-35E7D522ED96Q36772001-AED5C77D-CD4F-4BEA-890B-F9769C57FF20Q37200722-7D026273-762F-4DD3-9A74-F8EB50337B88Q37201511-181AFC5E-DFFB-45CA-A399-9552212C2620Q37362677-B03D12FB-69FF-459F-8C5C-11F081C69E0EQ37607600-A3F1D066-0340-4DD6-B684-346113E97ED2Q38318403-E74FB3F2-8D79-4B60-98B2-408A9FD72AEDQ38682140-B6F4C284-1843-49E7-A45B-BAD840D3B458Q38708671-D7A9213E-4F39-4372-852A-EF48E26B0C30Q38734026-8F880462-B1C3-42F2-9B68-B51DC7E61B4DQ38892406-5EC0949F-1549-4255-B2ED-97DB94E05F67Q38973727-B24A47AD-20D9-473E-8D4E-0334F62F04C9Q39172224-67CE7DEA-3ED0-4B45-82E8-E0CC086B4BF9Q39208543-26DF14E8-5E33-48DD-8D70-1C0476CA4088Q39393593-9EE023A8-9BAC-4CE9-8EE4-F3DAC9542EE7Q39396408-2747A1A7-BAE0-48BE-8B74-162867059DE2Q39515321-1715E791-CB27-485C-BB9E-5618C3A3AFFDQ40996633-22A1B8FB-010C-4792-A955-1A25CDA53D4EQ41036251-0F2C4B67-10B1-4BF9-9B58-4DB0766EF280Q41145166-9A6814B4-BB16-4B4D-9F1E-0AC2436D0CB2Q41880464-946E7305-2DB9-4F75-ADE1-883A4C5EA858Q43778009-07BA1438-C6D4-495B-BD46-FBD1158CF13D
P2860
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@ast
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@en
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@nl
type
label
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@ast
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@en
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@nl
prefLabel
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@ast
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@en
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@nl
P2093
P2860
P356
P1476
Inhibition of breast cancer ce ...... tein kinase signaling pathway.
@en
P2093
Frank E Jones
Lauren M Slakey
Matthew E Burow
Steven M Hill
P2860
P2888
P356
10.1186/BCR2794
P577
2010-12-17T00:00:00Z
P5875
P6179
1034708109